VWF and COVID-19: A high incidence of thrombosis, shown by increased immunostaining intensity for VWF in pulmonary vascular endothelium of patients with a disease duration of more than 10 days, confirmed the hypothesis of circulatory disorder progression during the entire period of COVID-19.